ACUTE RESPIRATORY VIRAL INFECTION
Clinical trials for ACUTE RESPIRATORY VIRAL INFECTION explained in plain language.
Never miss a new study
Get alerted when new ACUTE RESPIRATORY VIRAL INFECTION trials appear
Sign up with your email to follow new studies for ACUTE RESPIRATORY VIRAL INFECTION, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New cold treatment for kids shows promise in major trial
Symptom relief Recruiting nowThis study tests whether a medicine called raphamin can safely shorten cold and flu symptoms in children aged 3 to 12. About 374 children will receive either raphamin or a placebo. The main goal is to see how quickly symptoms like fever and congestion go away.
Matched conditions: ACUTE RESPIRATORY VIRAL INFECTION
Phase: PHASE3 • Sponsor: Materia Medica Holding • Aim: Symptom relief
Last updated May 17, 2026 07:52 UTC
-
New flu pill aims to cut sick days in half – clinical trial underway
Symptom relief Recruiting nowThis study tests whether a higher-dose version of the antiviral drug Ingavirin can help people with flu or other viral respiratory infections feel better faster. About 300 adults aged 18 to 65 with confirmed infections will receive either the new dose, the standard dose, or a pla…
Matched conditions: ACUTE RESPIRATORY VIRAL INFECTION
Phase: PHASE2 • Sponsor: Valenta Pharm JSC • Aim: Symptom relief
Last updated Apr 30, 2026 15:49 UTC